Introduction: Adult-onset Still's disease, an auto-inflammatory disease, is well described in the literature and tends to respond well to IL-1 blockade. A sub-group of adult patients may present with some of the typical symptoms and findings whichare commonly associated with autoinflammatory conditionsbut may not fulfil the criteria to obtain aspecific diagnosis. It has been reported in the literature that these patients may represent an 'undifferentiated systemic autoinflammatory disorder' and case reports support the use of anakinra as a viable treatment option in this sub-group. Case description: A 54-year-old female presented to rheumatology in 2014 with a two year history of recurrent episodes of sore throat, pyrexia, night sweats, polyarthralgia, headaches and bilateral episcleritis. Each episode recurred monthly and lasted three to five days before resolving. This patient's condition did not fulfil Yamaguchi's criteria for adult-onset Still's disease. Investigations revealed an elevated ferritin which ranged between 500-2700, CRP greater than 300, ESR greater than 120. Extensive investigations excluded an infective or malignant cause and included virology, autoimmune and vasculitis screen, IGRA, blood cultures, transthoracic echo, ultrasound abdomen, CT chest/abdomen/pelvis and CT-PET scan. Genetic screening for hereditary autoinflammatory disorders was negative. Serum immunoglobulins (including IgD) and serum protein electrophoresis was unremarkable. The patient's symptoms and inflammatory markers were responsive to high dose oral prednisolone, however, her symptoms recurred with steroid tapering. The patient was commenced on Methotrexate 25mg once weekly by subcutaneous injection to facilitate steroid weaning in 2015. The patient initially responded well to Methotrexate and was successfully weaned off steroids completely, she remained asymptomatic for two years. In 2017, she experienced frequent flares of her condition and continued to have active episcleritis on ophthalmological assessment. The patient required multiple courses of oral prednisolone to control her regular flares. The decision was taken to commence the patient onanakinra 100mg once daily subcutaneous injections one year ago in combination with methotrexate. The patient's condition has remained in remission since commencing anakinra in 2018 with resolution of her symptoms, episcleritis and serum inflammatory markers and is nolonger requiring oral prednisolone. Discussion: This patient exhibited signs and symptoms which are commonly associated with auto-inflammatory conditions. Due to the clinical phenotypeand negativegenetic testing, this patient did not fulfil anycriteria to be diagnosed with a specific auto-inflammatory disease. She did not fulfil Yamaguchi's criteria for adult-onset Still's disease. It is likely that this patient represents a case of 'atypical adult-onset Still's disease' or an 'undifferentiated systemic autoinflammatory disorder' which is supported by herexcellent responseto IL-1 blockade in the form of anakinra. Key learning points: This case highlights the importance of considering 'undifferentiated systemic autoinflammatory disorder' or 'atypical adultonset Still's disease' as a potential diagnosis for the subgroup of patients presenting atypically who do not fulfil any current classification or diagnostic criteria for a specific autoinflammatory disease. This case also illustrates that IL-1 blockade is potentially a viable treatment option in these patients.
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FEVER, DYSPNOEA AND A RAISED CRP: JUST ANOTHER CHEST SEPSIS?
Edward Davies 1 , and Vijay Hajela 1 1 Rheumatology, Brighton and Sussex University Hospitals NHS Foundation Trust, Brighton, United Kingdom Introduction: Autoinflammatory conditions can arise in patients presenting on the medical take. Patients presenting with an inflammatory response, fever and organ dysfunction are usually (and appropriately) managed as sepsis until proven otherwise. However, a suspicion should be maintained for alternative diagnoses when there is no improvement with conventional antimicrobial therapy. We present a case of a young woman presenting with polyserositis with a wide differential diagnosis including infection, autoimmunity and malignancy. She was treated successfully with colchicine. Subsequent genetic analysis at the Royal Free hospital for fever syndromes has not found a pre-described genetic polymorphism. Case description: A 39-year-old woman presented to A&E with dyspnoea,night sweats,lethargyandrightupperquadrantpain.Herpastmedical history included hypothyroidism and two years of intermittent diarrhoea. This diarrhoea was associated with a raised faecal calprotectin. Subsequent investigation with colonoscopy and MRI small bowel were normal. Other past history included pleurisy felt to be secondary to a lower respiratory tract infection aged 38 and a right knee effusion aged 15. She was born inthe UKbut had aGreekmother. Examination revealed reduced breath sounds in the bases which were dull to percuss, normal heart sounds and mild abdominal distension. There was no peripheral oedema. Observations showed oxygen saturations of 90% on air, BP 90/50, HR 120 and a pyrexia of 38 C. Blood results showed araised ALT of 100and CRP 40.She was initially treated withantibiotics for aworking diagnosis of atypical pneumonia. Her respiratory failure deteriorated and a CTPA two days later showed bilateral pleural effusions, a massive pericardial effusion with impending tamponade and a right upper lobe PE. A CT CAP show moderate ascites but noevidence of malignancy orlymphoma. Pericardiocentesis showed a reactive picture with no organisms grown and normal cytopathology of the fluid. Pleural and ascitic fluid were also drained and she was commenced on LMWH for the PE. Virology, microbiological and autoimmune screens were unremarkable. CRP at this stage had risen to78 as had the ALT to 1400. 6 days after admission, antibiotics were stopped shewas commenced on colchicine 1mg bd. Within 48 hours she rapidly improved both clinically and biochemically. Discussion:Since the index admission genetic analysis has shown sheis HLA B51 negative and she has no recognised genetic polymorphism associated with a periodic fever syndrome. 20 months since admission she has made a good recovery and is stable on colchicine 1mg od with no recurrence of the pleural and pericardial effusions. She has had one further episode of diarrhoea for 2 weeks associated with a raised faecal calprotectin and red macular rashes on her torso. Anticoagulation forthe PE hasbeen stopped. Polyserositis in the absence of infection or malignancy is uncommon and autoinflammatory and autoimmune aetiologies should be considered. This case highlights the importance of keeping a broad mind in patients presenting in an unusual way or when they do not respond to initial treatment. Autoinflammatory conditions are characterised by marked inflammation affecting the skin, serosal surfaces and synovium among others. Her history of colitis is intriguing. There are case reports of patients with familial Mediterranean fever presenting with serositis but she was negative for FMF on further genetic testing. Similarly she did not prove to have any of the genes that have so far been recognised as causing a periodic fever syndrome. We did considerBehc¸et's butshedenied ahistoryof recurrent oral orgenital ulceration or iritis and there was no family history. However Behc¸et's can lead to inflammatory bowel disease and this remains an intriguing possibility. Introduction: We describe a case of a 40-year-old male with recurrent episodes of fever, polyarthralgia, myalgia and pharyngitis. Investigations revealed intermittent transaminitis and high serum ferritin, but also positive streptococcal serology, despite negative microbiology. This case illustrates the challenges faced when diagnosing adult-onset Still's disease (AOSD) and distinguishing between alternative diagnoses, such as post streptococcal reactive arthritis (PSRA). It is important to differentiate between these conditions as theyhave different organ involvement,monitoringrequirements,treatments andprognoses. Thiscasehasprompted a review of studies where the frequencies of clinical and serological features are noted in these two conditions. Case description: A 40-year-old male was referred to acute medicine with3monthsofheadache, fatigue, polyarthralgia, myalgia,nightsweats, lymphadenopathy and otalgia. He reported a severe pharyngitis at symptom onset, 12 weeks earlier, for which he was given 20 days of phenoxymethylpenicillin by his GP. His sore throat improved, but his other symptoms persisted. His GP then suspected sinusitis, so prescribed doxycycline. He had no significant past medical history other than a tonsillectomyin his 20sand had been onnoregularmedication. On admission, he reported fever, headache, sweats, myalgia and arthralgia ofthe elbows andwrists.Hehad nomeningismanddenied anyrashes, nasal discharge, joint swelling, neurological symptoms, weight loss or symptoms to suggest underlying malignancy. An ENT specialist felt sinusitis to be unlikely. On examination, the initial positive findings included tenderness of the right mastoid process, low grade cervical lymphadenopathy, tender wrists, erythematous pharynx and myalgia of the thighs. There was no rash, clinical synovitis, ororganomegaly. ASOT levels were elevated and rose after presentation, whilst pharyngitis had been evident at symptom onset, which could imply an alternative differential of PSRA.
Identification of AOSD is important as it necessitates monitoring forcardiopulmonary manifestations and rarely macrophage activation syndrome. In AOSD, IL6-IL1 blockade is used for recalcitrant disease. For PSRA, it is important to ensure there are no features of acute rheumatic fever, renal disease,or cardiac disease. PSRA was less likely due to liver and ferritin abnormalities, which persisted long after CRP normalisation, persistent lymphadenopathy and negativethroat swabs. Therise in ASOT was considered afalse positive. The table compares clinicaland serological features forthe conditions. Key learning points: There can be diagnostic uncertainty regarding the diagnosis of AOSD, particularly as other conditions may share clinical features, such as recurrent pharyngitis with polyarthralgia/arthritis. PSRA is an important condition to keep in mind when investigating and managing these patients.
Both conditions can present with polyarthralgia, but the chronic arthritis of AOSD can progress to destructive arthropathy. The rashes in both conditions generally differ, helping to distinguish between the two. Persistent pyrexia and pharyngitis would be rare in PSRA unless the patient is having recurrent streptococcal infections. Therefore,it is important toperform ENT examinationwith bacterial throat swabs and forthe patient to keep afever diary. Similarly, cervical lymphadenopathy should only be present during the acute phase of the streptococcal infection rather than persistently, as in the case of AOSD.
Hepatosplenomegaly and haematological manifestations are more strongly associated with AOSD, so if these features are present there is greater diagnostic certainty, as long as infection and malignancy can be ruled out.
ASOT can be falsely positive due to cross reactivity with myeloma, liver disease, hypergammaglobulinaemia, and autoimmune disease associated with increased rheumatoid factor. ASOT levels peak at 3 weeks and decrease at 8 weeks, and only decreases to pre-infectious levels at 8 months. Anti-DNAse B peaks at 6-8 weeks, decreases at 12 weeks and returns to pre-infectious levels at 12 months. Therefore, the timeline of possible streptococcal infection is important, as even if the infection was months prior, ASOT may be elevated. Repeating both titres is useful, as a disproportionate rise in anti-DNASe B compared with ASOT suggests an acute infection. ASOT may remain elevated for many months in the pharyngeal carrierstate. It wouldbeinterestingtoclarifythe experience of othercentresinthe identificationof raised ASOT in AOSD.
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SEPSIS?
Hannah Zacharias 1 , and Tony Chan 1 1 Rheumatology, Royal Berkshire Hospital, Reading, United Kingdom Introduction: Sepsis is a major cause of mortality and there have been many patient safety initiatives to improve the outcome such as 'Think Sepsis' and 'Sepsis 6'. It is essential to consider mimics of sepsis in those presenting with fever, particularly when there is no improvement despite antimicrobials. Macrophage activation syndrome (MAS) is a complication of uncontrolled inflammation from underlying connective tissue disease resulting in a sepsis-like condition. Delay to the detection and treatment of this condition can also result in significant morbidity and mortality. Case description: We report a 28-year-old female presenting with shortness of breath, chest pain, bilateral leg swelling and fevers. Relevant past medical history included a recent diagnosis of Graves' disease for which she had been commenced on carbimazole. On presentation CRP 53 mg/ L and d-dimer 14100, chest X-ray; cardiomegally and bilateral pleural effusions, CT thoracic aorta angiogram; large pericardial effusion with maximum depth 5.9cm and compression of the cardiac chambers. Echocardiogram; preserved ejection fraction of 55-60%. The patient was commenced on intravenous antibiotics, furosemide and pericardial drain removed1.5L. The patient was referred to the rheumatology team on day 10. She reported episodic arthralgia, recurrent mouth ulcers, anaemia; with no evidence of haemolysis and pericardial effusion (serositis). Serology; ANA 1:1280 fine speckled pattern, dsDNA > 200, ENA positive (RNP and Smith antibodies) and low complement; C3 (0.35) and C4 (0.005), ferritin 1400, CRP 40 and ESR 62; consistent with a diagnosis of systemic lupus erythematosus (SLE). The patient was pulsed with IV methylprednisolone 500mg onDay 13 and started on prednisolone 40mg and azathioprine. Day 16; the patient developed a new pyrexia and profound hypotension resulting in admission to intensive care unit for inotropic support and escalation of antibiotics. Bedside echo revealed a small volume pericardial fluid; no tamponade, but significant new biventricular failure. Repeat
